Global Alzheimer Disease Genetic Testing Supply, Demand and Key Producers, 2023-2029

Global Alzheimer Disease Genetic Testing Supply, Demand and Key Producers, 2023-2029

The global Alzheimer Disease Genetic Testing market size is expected to reach $ 358.7 million by 2029, rising at a market growth of 17.6% CAGR during the forecast period (2023-2029).

Alzheimer's disease is a neurodegenerative disorder that affects memory, cognitive functions, and behavior. While there is no cure for Alzheimer's disease, early detection and treatment can help slow the progression of the disease. Genetic testing can be a useful tool in identifying individuals who may be at higher risk of developing Alzheimer's disease.

This report studies the global Alzheimer Disease Genetic Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Alzheimer Disease Genetic Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Alzheimer Disease Genetic Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Alzheimer Disease Genetic Testing total market, 2018-2029, (USD Million)

Global Alzheimer Disease Genetic Testing total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Alzheimer Disease Genetic Testing total market, key domestic companies and share, (USD Million)

Global Alzheimer Disease Genetic Testing revenue by player and market share 2018-2023, (USD Million)

Global Alzheimer Disease Genetic Testing total market by Type, CAGR, 2018-2029, (USD Million)

Global Alzheimer Disease Genetic Testing total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Alzheimer Disease Genetic Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mega Genomics, Blueprint Genetics, Generi-Biotech, RxHomeTest, Kashi Labs, 23andMe, LabCorp, Empower DX and SolGent, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Alzheimer Disease Genetic Testing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Alzheimer Disease Genetic Testing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Alzheimer Disease Genetic Testing Market, Segmentation by Type
Early-Onset Alzheimer Disease
Late-Onset Alzheimer Disease

Global Alzheimer Disease Genetic Testing Market, Segmentation by Application
Online
Offline

Companies Profiled:
Mega Genomics
Blueprint Genetics
Generi-Biotech
RxHomeTest
Kashi Labs
23andMe
LabCorp
Empower DX
SolGent
CapitalBio
Genex Diagnostics
Sansure

Key Questions Answered

1. How big is the global Alzheimer Disease Genetic Testing market?

2. What is the demand of the global Alzheimer Disease Genetic Testing market?

3. What is the year over year growth of the global Alzheimer Disease Genetic Testing market?

4. What is the total value of the global Alzheimer Disease Genetic Testing market?

5. Who are the major players in the global Alzheimer Disease Genetic Testing market?

6. What are the growth factors driving the market demand?